Screener
ICU Medical ICUI Vital Care — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: ICU Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000883984-26-000041
| Product line | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Consumables | $289,276 | $273,133 | $567,551 | $539,359 |
| Infusion Systems | 188,998 | 167,696 | 368,602 | 333,996 |
| Vital Care (1) | 73,409 | 108,037 | 145,755 | 280,213 |
| Total Revenues | $551,683 | $548,866 | $1,081,908 | $1,153,568 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is ICU Medical's vital care — revenue?
- ICU Medical (ICUI) reported vital care — revenue of $73.41M in Q2 2026.
- How has ICU Medical's vital care — revenue changed year-over-year?
- ICU Medical's vital care — revenue decreased by 32.1% year-over-year, from $108.04M to $73.41M.
- What is the long-term trend for ICU Medical's vital care — revenue?
- Over 4 years (2021 to 2025), ICU Medical's vital care — revenue has grown at a 1.7% compound annual growth rate (CAGR), from $408.8M to $437.92M.
- What does vital care — revenue mean?
- This metric represents the total gross sales generated by the Vital Care business segment, which focuses on specialized medical devices and clinical support products. It serves as a primary indicator of the segment's market demand and its contribution to the company's overall top-line performance. Tracking this revenue stream helps investors assess the growth trajectory and commercial success of the company's vital care product portfolio.
Ask your AI about ICU Medical's vital care — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude